An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies.
Ankhi DuttaAshley IkwuezunmaMaria I CastellanosJulienne BrackettKiranmye ReddyPriya MahajanAnn M MarshburnKala Y KamdarHana PaekDebra L PalazziKaren R RabinMichael E ScheurerMaria Monica J GramatgesPublished in: Pediatric blood & cancer (2021)
An evidence-based, risk-adapted approach to antifungal prophylaxis for children with hematologic malignancies is an effective strategy to reduce incidence of IMI.
Keyphrases